Free Stipulation - District Court of Delaware - Delaware

Case 1:04-cv-OO939—Gl\/IS Document 51 Filed O1/27/2006 Page 1 of 2
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE A
MERCK & CO., INC., )
Plaintiff, g
V- ) C.A. N0. 04-939 (JJF)
TEVA PHARMACEUTICALS USA, INC. g
Defendant. §

STIPULATION AND ORDER
Plaintiff,iMerck & Co., Inc. (°‘Merck") and Defendant Teva Pharmaceuticals USA, Inc.
("Teva") agree as follows:
Teva hereby stipulates that the commercial marketing of Teva’s proposed 35 mg h
risedronate sodium tablets, in accordance with ANDA N0. 77-I32, would infringe claims 20 and
34 of U.S. Patent No. 5,994,329 if those claims are valid.
This stipulation is in regard to the above—listed claims only, and for purposes of
the above captioned litigation only, and has no bearing on the patent claims of any other patent
belonging to Merck or any future claims that may arise from any amendment to ANDA No. 77-
132. This stipulation is not evidence of the infringement of any claim of any existing or future
patent belonging to Merck, except for the claims specifically listed herein.
E%”.n‘??$$$?3li9‘”‘ 0589561014

Case 1:04-cv-OO939—Gl\/IS Document 51 Filed O1/27/2006 Page 2 of 2
MORRIS, NICHOLS, ARSHT & YOUNG, CONAWAY STARGATT &
TUNNELL L.L.P.‘ TAYLOR, LLP
By /s/ Mary B. Graham By é %é&%/ X!
Mary B. Graham (#2256) J sy W. Ingersoll (# 088)
1201 N. Market St. Karen E. Keller (#4489)
P.O. Box 1347 The Brandywine Building
J Wilmington, DB 19899 1000 West Street, 17th Floor
(302) 658-9200 Wilmington, DE 19899
[email protected] (302) 571-6600
l Attorneys for Plaintiff Attorneys for Defendant
Merck & Co., Inc. Teva Pharmaceuticals USA, Inc.
Dated: January 27, 2006 Dated: January 27, 2006
W SO ORDERED this day of 2006. `
United States District Court Judge
DB0l:l97770l.l 2 0589561014